Location History:
- Offenbach am Main, DE (1987)
- Offenbach, DE (1987 - 1989)
- Dietzenbach, DE (1991 - 2003)
Company Filing History:
11 out of 112 
10 out of 29 
3 out of 1,678 Years Active: 1987-2003
Title: Helmut Hettche: A Pioneering Inventor in Pharmaceutical Dosage Units
Introduction:
Helmut Hettche, a prolific inventor based in Dietzenbach, DE, has made significant contributions to the field of pharmaceuticals with a total of 25 patents to his name. His innovative work focuses on oral forms of administration with controlled release of active substances, notably in the realm of pain management.
Latest Patents:
Hettche's recent patents showcase his expertise in developing pharmaceutical dosage units that offer controlled release mechanisms for active substances. One such patent involves oral forms containing solid flupirtine, a potent pain reliever. These dosage units effectively control the release of flupirtine, ensuring a sustained and effective delivery of the active substance while reducing its sedative effects.
Another notable patent by Hettche pertains to dosage forms containing thioctic acid or solid salts of thioctic acid. These novel formulations enhance the release and bioavailability of the active ingredient, providing more efficient therapeutic outcomes compared to previous dosage forms.
Career Highlights:
Throughout his career, Hettche has been associated with esteemed pharmaceutical companies such as Asta Medica and Asta Pharma. His invaluable contributions to drug delivery systems and pharmaceutical formulations have garnered recognition within the industry.
Collaborations:
Hettche has collaborated with talented professionals in the field, including Heinz Ulrich and Jurgen Engel. Together, they have worked on innovative projects that have pushed the boundaries of pharmaceutical technology and enhanced patient care.
Conclusion:
Helmut Hettche's dedication to advancing pharmaceutical dosage units has solidified his position as a leading inventor in the industry. His groundbreaking work in controlled release mechanisms and enhanced bioavailability underscores his commitment to improving healthcare outcomes.